Brazil delays Chinese vaccine efficacy report, keeps rollout date


  • World
  • Tuesday, 15 Dec 2020

FILE PHOTO: Brazil's Sao Paulo state governor, Joao Doria, and director of Instituto Butantan, Dimas Tadeu Covas, hold boxes of the China's Sinovac vaccine against the coronavirus disease (COVID-19) as a cargo plane containing the vaccines arrives at Sao Paulo International Airport in Guarulhos, Brazil November 19, 2020. REUTERS/Amanda Perobelli

SAO PAULO (Reuters) - Brazil's Sao Paulo state delayed on Monday the release of efficacy data for the COVID-19 vaccine developed by China's Sinovac, tightening the timeframe for regulator approval before a planned roll out on Jan. 25.

Governor Joao Doria said in a radio interview on Monday the data would be released on Dec. 23, eight days later than planned, to allow for a larger sample size and more complete analysis.

Earlier on Monday, João Gabbardo, head of Sao Paulo's COVID-19 response, said the delay would allow the efficacy analysis to include data from a sample including 151 infected people, making it a definitive rather than a preliminary report.

Doria's announcement that Sao Paulo will begin public vaccinations on Jan. 25, with the Chinese vaccine it has sourced independently, has angered the federal government of President Jair Bolsonaro, which has yet to set a date for a national immunization campaign.

On Sunday, Supreme Court Justice Ricardo Lewandowski ordered the Health Ministry to clarify within 48 hours when the federal government planned to begin public vaccinations.

Although Brazil has an enviable record for national vaccinations and a public health system well set up for such campaigns, Bolsonaro has repeatedly denied the gravity of the virus and is a vaccine skeptic who has said he will not take a COVID-19 shot.

Doria's public pressure has also irritated health regulator Anvisa, increasingly run by Bolsonaro allies.

Last week Sao Paulo's biomedical center, the Butantan Institute, began producing the Sinovac vaccine in a fill-and-finish process that will have a capacity of 1 million doses a day.

Despite not having federal approval for the vaccine, the production - at a time when the world is scrambling for shots - has drawn interest from governors across Brazil and countries across Latin America.

(Reporting by Eduardo Simoes, writing by Carolina Mandl and Stephen Eisenhammer, editing by Chris Reese)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In World

Existing emissions pledges barely scratch climate targets, U.N. tally finds
J&J COVID-19 vaccine set to get EU nod in early March - Bloomberg News
G20 should not withdraw fiscal support too early: Germany's Scholz
Moscow says U.S. gave Russia several minutes of warning before Syria strike - RIA
U.N. human rights boss urges Saudi Arabia to allow free speech, assembly
U.S. air strikes on Iran-backed militias in Syria kill at least one fighter
Denmark climate goal too reliant on unproven tech, govt council says
U.S. House on verge of approving Biden's $1.9 trillion COVID-19 aid bill
Kremlin critic Navalny moved to detention centre, says Russian prison authority - RIA
Japan to end state of emergency for six prefectures this month

Stories You'll Enjoy


Vouchers